Latest News

NEW – In vivo models of Psoriasis and Psoriatic arthritis

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting the skin but up to a third of the patients also have involvement of other organs such as joints resulting in psoriatic arthritis. For more information on our models for these diseases […]

Read more

Newest member of our team – Frida

We are, since december, happy to have Frida on our team of researchers. Frida just finished her master in molecular biology at the University of Lund with a focus on immunology and neurobiology and will strengthen our in vivo team. Welcome Frida!

Read more

Applications invited

Applications are invited for 14 ESRs (Early Stage Researchers) funded by the Marie-Sklodowska-Curie Innovative Training Network COSMIC (Combatting disorders of adaptive immunity with systems medicine; project 765158) within the European Horizon 2020 Programme. COSMIC is an international consortium of high profile universities, research institutions and companies located in Germany, Italy, France, Greece, the United Kingdom, […]

Read more

Redoxis a part of COSMIC

As of the first of January 2018 Redoxis is a part of the international consortium COSMIC. COSMIC systems medicine training and research programme kicks off! An international consortium coordinated by the Academic Medical Center in Amsterdam received funding from the H2020 Marie Skłodowska-Curie programme to implement COSMIC (COmbatting disorders of adaptive immunity with Systems MedICine; […]

Read more

Meet us at BioEurope 6-8 November, Berlin

We will be at the BioEurope meeting in Berlin from 6-8 of November. Take the opportunity to meet with us for a presentation of our services and models. Sebastian (sebastian.hansson@redoxis.com) will be happy to discuss further with you how we could be of assistance for your preclinical project.

Read more